Following chemotherapy for breast cancer, ONECUT2 induces tumor stemness and triggers the expression of stem cell-related genes, including SOX9, SOX2, and NOTCH1, thereby contributing to chemoresistance [25]. Here, NOTCH1 is linked to neoplasm.